Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Author/Authors :
Kim Fox، نويسنده , , Ian Ford، نويسنده , , P Gabriel Steg، نويسنده , , Michal Tendera، نويسنده , , Michele Robertson، نويسنده , , Roberto Ferrari، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
5
From page :
817
To page :
821
Abstract :
Summary
Background
The BEAUTIFUL study assessed the morbidity and mortality benefits of the heart rate-lowering agent ivabradine. The placebo arm of the BEAUTIFUL trial was a large cohort of patients with stable coronary artery disease and left-ventricula
